Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

Weigh risks, plan ahead prior to gathering for the holidays

Vanderbilt University Medical Center infectious disease experts advise this is the season to think very wisely about planned get-togethers.

The Yazdani sisters are triplets by birth, proud VUMC nurses by choice

Sousan, Sohayla and Setareh Yazdani are 22-year-old triplets who all work as nurses at VUMC. They agree that they always wanted to pursue their careers at Vanderbilt.

Surveys show VUMC patients value immediate online access to test results

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit

Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C.